Therapy News and Research

RSS

Surgical biopsies can be safely performed on selected patients with late-stage lung cancer

Researchers at UC Davis have determined that surgical biopsies can be safely performed on select patients with late-stage non-small cell lung cancer, which should enhance their access to drugs that target specific genetic mutations such as epidermal growth factor receptor (EGFR).

27 Jun 2014

Blocking enzyme Cdk5 could reduce brain damage after stroke

A drug that blocks the action of the enzyme Cdk5 could substantially reduce brain damage if administered shortly after a stroke, UT Southwestern Medical Center research suggests.

27 Jun 2014

Antidepressant risk in bipolar patients limited to monotherapy use

Antidepressants may cause problems in patients with bipolar disorder only when they are used in isolation, research suggests.

26 Jun 2014

Scientists report first successful step toward vaccine that targets mutation in brain cancer

Astrocytomas and oligodendrogliomas are subtypes of a brain cancer called 'glioma'. These incurable brain tumors arise from glial cells, a type of support cell found in the central nervous system.

26 Jun 2014

Ivenix develops groundbreaking infusion management platform to transform infusion pump market

Ivenix, Inc. today announced that it is developing a groundbreaking infusion management platform designed to transform the infusion pump market by helping to improve patient safety and clinical workflow efficiency.

26 Jun 2014

Jackson Laboratory Cancer Center earns renewal of Cancer Center Support Grant from NCI

The Jackson Laboratory Cancer Center has once again earned the renewal of its Cancer Center Support Grant from the National Cancer Institute (NCI).

26 Jun 2014

Administering low doses of thyroid hormone to rats with diabetes prevents deterioration of heart function

Administering low doses of a thyroid hormone to rats with diabetes helps restore hormone levels in their hearts and prevented deterioration of heart function and pathology, according to a new study by NYIT College of Osteopathic Medicine Professor and Biomedical Sciences Chair A. Martin Gerdes.

26 Jun 2014

DBS improves motor and non motor symptoms of patients with early Parkinson's disease

Deep brain stimulation (DBS) has become a well-recognized non-pharmacologic treatment that improves motor symptoms of patients with early and advanced Parkinson's disease.

26 Jun 2014

Response-adaptive randomization approach can boost patients’ participation in medical studies

It's a classic Catch-22: Medical researchers need to figure out if a promising new treatment is truly better than a current one, by randomly assigning half of a group of patients to get each treatment.

26 Jun 2014

Queen's doctor plays key role in major breakthrough to change lives of cystic fibrosis sufferers

A Queen's University doctor has played a key role in a major breakthrough to change the lives of cystic fibrosis sufferers.

26 Jun 2014

Researchers aim to fight cancer by developing 'personalised' cancer therapies

Cancer is incredibly complex, and each tumour is unique. This calls for a targeted approach. Researchers at KU Leuven's Department of Oncology, in Belgium, want to fight cancer by developing 'personalised' cancer therapies. To bolster their efforts, they have established the new Fund for Innovative Cancer Research.

26 Jun 2014

Scientists use femtosecond lasers to tackle Parkinson's disease

Scientists are combining physics and neurobiology to tackle Parkinson's disease. The Okinawa Institute of Science and Technology Graduate University's Femtosecond Spectroscopy Unit and Neurobiology Research Unit, along with collaborators at the University of Otago, New Zealand are using lasers, nanotechnology and neuroscience to develop a new, versatile drug delivery system.

26 Jun 2014

Study explains why people with disrupted circadian rhythms can be more susceptible to cancer

Research led by the University of Warwick's Systems Biology Centre and Medical School in collaboration with groups in Nice and Rotterdam has been able to demonstrate how the cycle of cell division in mammalian cells synchronises with the body's own daily rhythm, its circadian clock.

26 Jun 2014

Molecule that blocks bone destruction could provide potential therapeutic target for osteoporosis

UT-Southwestern cancer researchers have identified a promising molecule that blocks bone destruction and, therefore, could provide a potential therapeutic target for osteoporosis and bone metastases of cancer.

26 Jun 2014

Adding MM-398 to standard treatment improves survival in metastatic pancreatic cancer patients

Adding the novel MM-398 to standard treatment for metastatic pancreatic cancer patients who have already received gemcitabine improves survival, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona.

26 Jun 2014

WebPT receives significant investment from Battery Ventures

WebPT, the leading web-based electronic medical record (EMR) solution for rehabilitation therapists, today announced it has received a significant investment from Battery Ventures. WebPT intends to use the new capital to accelerate growth.

25 Jun 2014

Key historical misconceptions hinder research and treatment for brain metastases

"Key historical misconceptions" are hindering progress in research and treatment for patients with cancer metastases to the brain, suggests a special article in the July issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

25 Jun 2014

Aerie Pharmaceuticals' Roclatan meets all clinical endpoints in Phase 2b trial

Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today reported the successful results of its Phase 2b trial for once-daily, quadruple-action RoclatanTM, a combination of Aerie's triple-action RhopressaTM with latanoprost, a prostaglandin analogue (PGA).

25 Jun 2014

Freelance journalist receives Endocrine Society's annual award

Freelance journalist Cathryn Jakobson Ramin received the Endocrine Society's annual Award for Excellence in Science and Medical Journalism, the Society announced today.

25 Jun 2014

Henry Ford launches clinical trial for treatment of tinnitus caused by noise trauma

Henry Ford Health System has launched a clinical trial to investigate a new drug for the treatment of tinnitus, a chronic ringing of the head or ears that affects more than 600 million people worldwide.

25 Jun 2014

Therapy News and Research

Surgical biopsies can be safely performed on selected patients with late-stage lung cancer

Blocking enzyme Cdk5 could reduce brain damage after stroke

Antidepressant risk in bipolar patients limited to monotherapy use

Scientists report first successful step toward vaccine that targets mutation in brain cancer

Ivenix develops groundbreaking infusion management platform to transform infusion pump market

Jackson Laboratory Cancer Center earns renewal of Cancer Center Support Grant from NCI

Administering low doses of thyroid hormone to rats with diabetes prevents deterioration of heart function

DBS improves motor and non motor symptoms of patients with early Parkinson's disease

Response-adaptive randomization approach can boost patients’ participation in medical studies

Queen's doctor plays key role in major breakthrough to change lives of cystic fibrosis sufferers

Researchers aim to fight cancer by developing 'personalised' cancer therapies

Scientists use femtosecond lasers to tackle Parkinson's disease

Study explains why people with disrupted circadian rhythms can be more susceptible to cancer

Molecule that blocks bone destruction could provide potential therapeutic target for osteoporosis

Adding MM-398 to standard treatment improves survival in metastatic pancreatic cancer patients

WebPT receives significant investment from Battery Ventures

Key historical misconceptions hinder research and treatment for brain metastases

Aerie Pharmaceuticals' Roclatan meets all clinical endpoints in Phase 2b trial

Freelance journalist receives Endocrine Society's annual award

Henry Ford launches clinical trial for treatment of tinnitus caused by noise trauma

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News